scholarly journals Evaluation of The Timing of The Use of Hyperbaric Oxygen Therapy and Prognostic Factors in Sudden Hearing Loss

2020 ◽  
Vol 3 (36) ◽  
pp. 232-237
Author(s):  
Abdullah Arslan
2018 ◽  
Vol 84 (1) ◽  
pp. 28-33 ◽  
Author(s):  
Filiz Gülüstan ◽  
Zahide Mine Yazıcı ◽  
Wesam M.E. Alakhras ◽  
Omer Erdur ◽  
Harun Acipayam ◽  
...  

2006 ◽  
Vol 135 (2_suppl) ◽  
pp. P223-P223
Author(s):  
Engin Çekin ◽  
Atila Gungor ◽  
Hakan Cincik

2014 ◽  
Vol 151 (1_suppl) ◽  
pp. P208-P208
Author(s):  
Erika Celis-Aguilar ◽  
Alan Burgos-Paez ◽  
Homero O. Mayoral-Flores ◽  
Yancy M. Bernal-Espinoza ◽  
Enrique G. López-Ramos

2008 ◽  
Vol 101 (10) ◽  
pp. 749-757 ◽  
Author(s):  
Makoto Miura ◽  
Tatsunori Sakamoto ◽  
Harukazu Hiraumi ◽  
Shinichi Kanemaru ◽  
Juichi Ito

2018 ◽  
Vol 69 (4) ◽  
pp. 952-955
Author(s):  
Dragos Cristian Stefanescu ◽  
Razvan Hainarosie ◽  
Viorel Zainea ◽  
Dan Corneci ◽  
Radu Cristian Jecan

The therapeutic approach in sensorineural hearing loss (ISSNHL) is far from a consensual protocol among ENT (ear, nose and throat) doctors. The present paper describes our experience with Hyperbaric Oxygen Therapy (HBOT) as salvage treatment for selected patients with the sudden sensorineural hearing loss. The HBOT method has shown an efficacy of 50% in our study, as salvage treatment in ISSNHL after initially corticoids therapy. Thus, we can assert without doubt that HBOT represents a viable option for those patients who want to continue the effort to regain hearing. Under the auspices of the national ENT society, through a collective effort, can be achieved a therapeutic consensus in the sensorineural hearing loss. In this consensual document, HBOT can be found both as initial and salvage therapy, alone or in the multimodal therapeutical variant. Further, the National Health Insurance House should introduce the reimbursement of HBOT sessions in the methodological norms, in order to offer this new therapeutic solution to all patients.


2017 ◽  
Vol 2017 ◽  
pp. 1-6 ◽  
Author(s):  
Massimo Ralli ◽  
Antonio Greco ◽  
Vincenzo Falasca ◽  
Giancarlo Altissimi ◽  
Mario Tombolini ◽  
...  

Hearing loss has been rarely reported in Takayasu’s arteritis, may present as Sudden Sensorineural Hearing Loss, and usually responds well to corticosteroid therapy. Hyperbaric Oxygen Therapy is commonly used as a supplementary treatment to corticosteroids for Sudden Sensorineural Hearing Loss. We present the case of a 36-year-old woman with Takayasu’s arteritis who had two episodes of sudden hearing loss involving one ear at a time with an 11-month delay between each episode. During the first episode, the patient was treated with high-dose intramuscular corticosteroids with a temporary improvement of auditory threshold that deteriorated 14 days after cessation of therapy. In the second episode, Hyperbaric Oxygen Therapy was associated with corticosteroids, with improvements in both ears, including the one that was unresponsive in the long term to previous pharmacologic therapy. In this case, Hyperbaric Oxygen Therapy could have acted synergically with corticosteroids playing a role in hearing restoration.


Sign in / Sign up

Export Citation Format

Share Document